
[BMJ Publishing Group Ltd and European League Against Rheumatism Annual European Congress of Rheumatology, 14–17 June, 2017 - ()] Poster Presentations - FRI0487 Apremilast is associated with long-term (4-YEAR) DAS-28 (CRP) remission and improvements in skin disease: results from a phase iii study in dmard/biologic-experienced patients with active psoriatic arthritis
Edwards, CJ, Blanco, FJ, Crowley, J, McIlraith, M, Paris, M, Delev, N, Teng, L, Birbara, CALangue:
english
DOI:
10.1136/annrheumdis-2017-eular.3563
Fichier:
PDF, 397 KB
english